three
major
soiltransmit
nematod
infect
word
ascariasi
trichuriasi
hookworm
infect
highli
preval
neglect
tropic
diseas
rank
near
top
list
common
human
afflict
accord
estim
approxim
million
peopl
infect
roundworm
ascari
lumbricoid
million
peopl
whipworm
trichuri
trichiura
hookworm
mostli
necat
americanu
widespread
geograph
overlap
three
soiltransmit
nematod
infect
also
refer
soiltransmit
helminth
intestin
helminth
intestin
nematod
geohelminth
infect
impoverish
area
subsaharan
africa
east
asia
south
asia
tropic
region
central
south
america
coinfect
two
even
three
soiltransmit
nematod
infect
extrem
common
children
current
estim
million
children
infect
expos
lumbricoid
trichiura
hookworm
therefor
requir
regular
period
anthelmint
treatment
deworm
tabl
children
often
chronic
infect
suffer
longterm
disabl
consequ
includ
growth
stunt
reduct
physic
fit
cognit
intellectu
delay
moreov
million
pregnant
women
develop
countri
soiltransmit
nematod
infect
especi
hookworm
infect
recent
estim
global
burden
diseas
studi
indic
soiltransmit
nematod
infect
respons
million
disabilityadjust
life
year
lead
neglect
tropic
diseas
addit
ascariasi
respons
death
annual
global
control
soiltransmit
nematod
infect
base
annual
sometim
twiceannu
mass
drug
administr
either
albendazol
mebendazol
children
age
year
live
area
preval
infect
exce
estim
world
children
requir
mass
treatment
actual
receiv
medic
current
pregnant
women
consist
receiv
anthelmint
treatment
even
though
might
benefit
deworm
second
third
trimest
asid
low
treatment
coverag
children
situat
remedi
expand
donat
albendazol
mebendazol
new
global
polici
includ
recent
world
health
assembl
resolut
concern
pediatr
mass
drug
administr
alon
may
suffici
effect
global
control
soiltransmit
nematod
infect
certainli
global
elimin
among
major
reason
annual
deworm
may
success
isol
intervent
recent
cochran
analysi
question
benefit
mass
treatment
deworm
base
lack
consist
evid
benefici
impact
nutrit
hemoglobin
school
attend
perform
like
factor
outlin
word
rapid
reinfect
lack
drug
efficaci
role
cochran
find
howev
cochran
analysi
also
differenti
effect
individu
nematod
speci
differenti
drug
suscept
exampl
hookworm
infect
link
anemia
children
adult
systemat
review
demonstr
benefit
albendazol
mebendazol
improv
anemia
cochran
analysi
partli
blur
find
treat
soiltransmit
nematod
infect
treatment
equival
nevertheless
inform
date
indic
urgenc
improv
effect
effici
global
deworm
order
achiev
key
mileston
millennium
develop
goal
approach
improv
global
deworm
recent
suggest
includ
ad
ivermectin
albendazol
area
high
level
trichuriasi
strongyloidiasi
transmiss
occur
possibl
ad
new
anthelmint
tribendimidin
novel
bacillu
thuringiensisderiv
crystal
protein
order
target
hookworm
still
anoth
approach
global
control
elimin
soiltransmit
nematod
infect
includ
develop
distribut
anthelmint
vaccin
hookworm
diseas
account
almost
twothird
global
diseas
burden
soiltransmit
nematod
infect
infect
select
initi
vaccin
develop
current
sabin
vaccin
institut
product
develop
partnership
develop
bival
recombin
proteinbas
human
hookworm
vaccin
vaccin
compris
two
necat
americanu
antigen
formul
alum
togeth
second
adjuv
compon
phase
clinic
trial
expect
follow
explor
concept
ad
ascari
trichuri
antigen
two
necat
hookworm
antigen
develop
order
launch
multival
pananthelmint
vaccin
soiltransmit
nematod
infect
briefli
review
statu
exist
ascari
trichuri
antigen
undergon
preclin
test
step
requir
perform
addit
antigen
discoveri
select
downselect
singl
vaccin
candid
antigen
one
nematod
preclin
evalu
process
develop
manufactur
good
laboratori
practic
toxicolog
preclin
evalu
earli
stage
clinic
test
larval
antigen
discov
immunoscreen
larval
cdna
librari
sera
rabbit
immun
infect
egg
antigen
found
larval
adult
ascari
worm
present
es
well
defin
parasit
structur
mice
vaccin
intranas
recombin
express
escherichia
coli
formul
cholera
toxin
b
subunit
exhibit
reduct
number
migrat
larva
mice
challeng
compar
control
mice
protect
associ
elev
host
antibodi
well
cultur
supernat
activ
spleen
cell
indic
mix
respons
also
transgen
express
rice
novel
oral
vaccin
deliveri
approach
ortholog
clone
lumbricoid
shown
ident
molecul
also
clone
suum
larval
cdna
use
immun
sera
pig
infect
repeatedli
suum
egg
nematodespecif
protein
express
e
coli
found
elicit
reduct
recoveri
suum
lungstag
larva
protect
associ
high
level
igg
elev
level
indic
mix
respons
igg
inhibit
molt
suum
lung
stage
indic
function
develop
ascari
larva
immunodomin
suum
larval
surfac
antigen
recogn
pig
immun
serum
molecul
contain
multipl
immunoglobulinlik
domain
also
found
adult
worm
lumbricoid
ortholog
clone
found
exhibit
amino
acid
homolog
molecul
elicit
reduct
larva
liver
lung
follow
lumbricoid
egg
challeng
ascari
suum
util
exogen
glucos
energi
gener
glycolyt
pathway
enolas
one
enzym
catalyz
synthesi
phosphoenolpyruv
ascari
suum
enolas
first
clone
suum
infect
larvaespecif
cdna
librari
use
microarray
analysi
also
identifi
one
major
secret
protein
suum
adult
es
product
trigger
nitric
oxid
product
macrophag
specif
knockout
rnai
result
delay
larval
develop
mice
immun
dna
code
exhibit
reduct
larva
recoveri
lung
compar
empti
plasmid
dna
control
protect
correl
high
level
specif
antibodi
lymphoprolif
respons
mani
parasit
nematod
glutathion
stransferas
belong
uniqu
nu
class
enzym
involv
heme
scaveng
detoxif
note
n
americanu
protect
antigen
found
human
hookworm
vaccin
suum
ortholog
exhibit
amino
acid
homolog
enzym
sinc
five
six
antigen
list
tabl
major
antigen
recogn
protect
immun
sera
induc
live
uvattenu
egg
compar
protect
efficaci
simultan
determin
requir
addit
antigen
discoveri
order
downselect
appropri
antigen
develop
recombin
antigen
compar
mous
challeng
model
recombin
protein
produc
appropri
express
system
ie
bacteria
yeast
baculoviru
use
immunogen
immunogen
studi
vaccin
trial
mous
model
parallel
proteom
approach
undertaken
evalu
addit
es
surfac
protein
suum
immunoreact
immun
serum
pig
model
backup
strategi
identif
vaccin
candid
goal
rank
top
two
candid
antigen
respect
efficaci
preclin
challeng
model
togeth
abil
express
antigen
solubl
protein
high
yield
see
correspond
antigen
lumbricoid
also
clone
express
examin
immunolog
crossreact
homogen
adult
muri
antigen
either
emulsifi
freund
complet
adjuv
subcutan
immun
combin
cholera
toxin
oral
administr
administ
sever
differ
mous
strain
mucos
respons
enhanc
oral
vaccin
suffici
protect
infect
low
respond
word
protect
achiev
balbc
highrespond
mice
result
similarli
found
oral
vaccin
trichinella
lead
protect
immun
highrespond
mice
contrast
subcutan
administr
provid
protect
immun
multipl
strain
vaccin
human
mice
immunodomin
kda
muri
antigen
identifi
worm
homogen
stichosomerel
adultstag
es
product
identifi
potenti
sourc
protect
antigen
although
note
stichosom
protein
remain
store
organ
actual
secret
partial
protect
observ
follow
immun
adult
es
product
especi
emulsifi
freund
incomplet
adjuv
protect
elicit
suscept
akr
mice
includ
reduct
parasit
egg
shed
associ
peripher
lymph
node
respons
find
crossreact
crossimmun
trichuri
trichinella
prompt
studi
share
antigen
use
elisa
immunoprecipit
immunoblot
demonstr
trichiurainfect
mice
crossreact
antibodi
spirali
share
stichocyt
antigen
also
note
among
defin
candid
antigen
identifi
spirali
provid
partial
protect
aminopeptidas
serin
proteas
parasitederiv
cytokin
paramyosin
heatshock
protein
kda
secret
antigen
unknown
function
outlin
defin
trichiuraspecif
antigen
specif
identifi
vaccin
develop
thu
still
need
discov
develop
specif
trichiura
antigen
one
approach
could
util
establish
muri
akr
murin
model
sinc
adult
es
product
muri
induc
complet
protect
immun
mice
infect
egg
challeng
immun
sera
use
immunoscreen
muri
adult
stichosom
cdna
librari
identifi
secret
protein
induc
protect
immun
anoth
approach
identifi
vaccin
antigen
take
advantag
studi
alreadi
complet
major
trichinella
antigen
highlight
previous
trichuri
muri
ortholog
antigen
highlight
clone
express
platform
bacteria
yeast
baculoviru
antigen
test
subsequ
immunogen
studi
parallel
proteom
approach
use
identifi
full
complement
muri
stichosom
antigen
reactiv
immun
serum
mous
model
promis
candid
identifi
protein
express
trichura
homolog
candid
begin
antigen
downselect
take
place
key
observ
made
clinic
test
human
hookworm
candid
antigen
human
popul
live
endem
area
acquir
ige
respons
select
antigen
especi
infect
larva
volunt
prevaccin
ige
develop
urticari
reaction
includ
gener
urticaria
upon
receiv
recombin
form
antigen
base
find
current
evid
prevaccin
antigenspecif
ige
antibodi
among
endem
popul
use
discard
downselect
potenti
candid
vaccin
larval
ascari
antigen
particular
close
scrutin
therefor
key
step
develop
vaccin
antigen
pipelin
prevent
allerg
respons
first
examin
sera
popul
live
area
endem
ascariasi
trichuriasi
select
lead
candid
antigen
reli
rank
score
system
assign
number
rang
critic
categori
describ
approach
use
previous
rank
lead
candid
hookworm
antigen
use
human
hookworm
vaccin
ascariasi
trichuriasi
major
criteria
includ
level
protect
immun
amino
acid
homolog
suum
lumbricoid
muri
trichiura
known
presum
mechan
action
absenc
prevaccin
ige
among
endem
popul
solubl
stabil
express
yield
lead
two
candid
ascari
trichuri
antigen
subject
protein
express
ferment
scale
largescal
protein
purif
anticip
gener
target
product
profil
would
focu
vulner
popul
live
helminth
endem
area
low
middleincom
countri
like
lowcost
express
system
yeast
eg
pichia
pastori
hansenula
polymorpha
bacteria
eg
e
coli
would
select
addit
product
yield
solubl
stabil
express
protein
would
evalu
immunogen
abil
induc
protect
immun
anim
model
highlight
process
develop
technolog
transfer
current
good
manufactur
practic
manufactur
usa
europ
possibl
develop
countri
manufactur
follow
good
laboratori
practic
toxicolog
studi
investig
new
drug
applic
would
prepar
file
us
fda
prior
phase
clinic
test
antigen
would
evalu
initi
monoval
antigen
formul
alum
possibl
togeth
second
adjuv
tolllik
receptor
agonist
use
vaccin
develop
sabin
vaccin
institut
product
develop
partnership
synthet
lipid
cpg
oligodeoxynucleotid
protein
differ
individu
characterist
eg
size
ph
buffer
excipi
provid
stabil
one
protein
may
suitabl
anoth
antigen
interest
extens
buffer
screen
may
requir
identifi
formul
ideal
vaccin
antigen
also
consid
necessari
storag
condit
formul
could
affect
longtim
storag
shipment
shortterm
storag
clinic
immun
respons
appear
desir
protect
respons
common
three
soiltransmit
nematod
target
vaccin
ensur
adjuv
appropri
antigen
wellestablish
rel
inexpens
option
use
alum
formul
possibl
second
adjuv
outlin
recur
concern
combin
multipl
antigen
vaccin
potenti
immun
interfer
exampl
immun
respons
one
antigen
may
domin
interfer
other
vaccin
endem
area
mani
peopl
suffer
helminth
infect
polyparasit
make
coinfect
anim
model
critic
vaccin
develop
current
multipl
anim
model
use
surrog
human
ascari
trichuri
infect
includ
rodent
pig
nonhuman
primat
rodent
pig
use
frequent
rodent
model
word
mice
rat
attract
pig
nonhuman
primat
initi
immunogen
efficaci
studi
small
size
eas
handl
allow
larger
number
anim
evalu
concurr
addit
genet
defin
inbr
strain
allow
identif
genet
background
respons
suscept
resist
parasit
sever
strain
includ
akr
scid
nude
shown
suscept
muri
develop
patent
infect
contrast
suum
larva
migrat
liver
lung
mice
date
mice
support
develop
adult
worm
patent
suum
infect
nonetheless
sever
suum
antigen
identifi
screen
immun
serum
pig
shown
reduc
lung
larval
burden
suscept
mice
suggest
protect
immun
respons
suscept
mice
correl
protect
respons
pig
sinc
mice
infect
low
dose
muri
develop
immun
respons
suscept
phenotyp
mous
strain
could
potenti
serv
initi
coinfect
model
evalu
panhelminth
vaccin
ascari
trichuri
infect
furthermor
mice
would
invalu
evalu
regulatori
mandat
immunogen
test
antigenadjuv
combin
futur
potenc
test
clinic
vaccin
ultim
thoroughli
evalu
coformul
vaccin
mice
pig
may
necessari
establish
suffici
protect
data
advanc
potenti
vaccin
candid
product
develop
pig
offer
promis
laboratori
vaccin
model
although
yet
use
extens
evalu
sui
studi
undertaken
assess
whether
studi
confirm
host
protect
pig
critic
path
vaccin
develop
use
build
previou
mathemat
model
helminth
transmiss
dynam
assess
level
protect
immun
necessari
achiev
rel
current
deworm
approach
previous
done
human
hookworm
vaccin
model
would
also
help
assess
potenti
vaccin
achiev
control
elimin
target
interrupt
helminth
transmiss
strategi
discoveri
express
isol
preclin
develop
advanc
lead
candid
antigen
prevent
ascariasi
trichuriasi
ultim
antigen
evalu
protect
alongsid
two
antigen
compris
human
hookworm
vaccin
may
necessari
produc
tetraval
vaccin
compris
two
hookworm
antigen
togeth
ascari
trichuri
antigen
respect
even
possibl
pentaval
vaccin
second
ascari
trichuri
antigen
requir
achiev
adequ
protect
immun
cost
vaccin
care
look
even
inexpens
bacteri
yeast
express
vector
employ
cost
econom
model
exercis
may
requir
examin
compar
advantag
pananthelmint
vaccin
current
control
approach
reli
anthelmint
drug
deworm
previous
human
hookworm
vaccin
shown
costeffect
even
costsav
differ
scenario
next
year
focus
work
resolv
major
gap
key
issu
could
hinder
slow
panhelminth
vaccin
develop
program
one
major
goal
spearhead
focus
antigen
discoveri
program
ascari
trichuri
eventu
downselect
detail
antigen
identifi
express
enter
process
develop
character
initi
stabil
assess
program
main
consider
includ
design
formul
support
stabil
candid
ascari
trichuri
antigen
also
human
hookworm
vaccin
antigen
anoth
key
endeavor
build
previou
preclin
studi
establish
suitabl
anim
model
pananthelmint
vaccin
model
would
support
immunogen
preclin
efficaci
studi
vaccin
candid
move
toward
investig
new
drug
file
clinic
trial
studi
critic
determin
protect
immun
achiev
helminth
antigen
laboratori
anim
translat
human
medicin
